CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 NRx Pharmaceuticals, Inc. - NRXP CFD

    -
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 -
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* N/A
    开仓* N/A
    1 年变化* N/A
    日范围* N/A
    52 周范围 0.49-1.54
    平均交易量（10 天） 696.74K
    平均交易量（3 个月) 4.73M
    市值 45.86M
    市盈率 -100.00K
    流通股 70.31M
    收入 N/A
    EPS -0.56
    股息（收益率 %） N/A
    贝塔 0.95
    下一个财报发布日期 Aug 14, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low

    NRx Pharmaceuticals, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Tuesday, July 18, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    NRX Pharmaceuticals Inc Annual Shareholders Meeting
    NRX Pharmaceuticals Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, August 14, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 NRX Pharmaceuticals Inc Earnings Release
    Q2 2023 NRX Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Q3 2023 NRX Pharmaceuticals Inc Earnings Release
    Q3 2023 NRX Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    总营业费用 44.335 115.675 0.55534 0.71319 1.0065
    销售/一般/行政费用，总计 27.308 74.944 0.90741 0.71319 1.0065
    营业收入 -44.335 -115.675 -0.55534 -0.71319 -1.0065
    利息收入（费用），非经营净值 0.504 1.674 -0.51633 1.20582 1.08892
    税前净收入 -39.754 -93.063 -1.07167 0.49263 0.08241
    税后净收入 -39.754 -93.063 -1.08951 0.40843 0.0661
    未计算非常项目前的净收益 -39.754 -93.063 -1.08951 0.40843 0.0661
    净收入 -39.754 -93.063 -1.08951 0.40843 0.0661
    普通股股东可获收益 (不含非经常性项目) -39.754 -348.885 -1.08951 0.40843 0.0661
    普通股股东可获收益 (含非經常性項目) -39.754 -348.885 -1.08951 0.40843 0.0661
    摊薄净收入 -39.754 -348.885 -1.08951 0.40843 0.0661
    摊薄后加权平均股 65.7668 46.9177 2.73626 5.08836 8.92497
    扣除特别项目的每股摊薄盈利 -0.60447 -7.43611 -0.39818 0.08027 0.00741
    Dividends per Share - Common Stock Primary Issue
    每股正常摊薄盈利 -0.60447 -6.98329 -0.48181 0.08027 0.00741
    异常费用（收入） 0 21.245 -0.35207
    研究与开发 17.027 20.257
    Other Operating Expenses, Total 0 -0.771
    其他，净值 4.077 20.938
    Total Adjustments to Net Income 0 -255.822
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    总营业费用 9.435 9.888 9.141 9.6 15.705
    销售/一般/行政费用，总计 5.785 5.432 5.012 6.642 10.222
    研究与开发 3.65 4.456 4.129 2.958 5.483
    异常费用（收入） 0 0 0 0
    Other Operating Expenses, Total 0 0 0 0
    营业收入 -9.435 -9.888 -9.141 -9.6 -15.705
    利息收入（费用），非经营净值 0.168 0.152 0.058 0.139 0.154
    其他，净值 -1.772 -0.505 0 2.479 2.103
    税前净收入 -11.039 -10.241 -9.083 -6.982 -13.448
    税后净收入 -11.039 -10.241 -9.083 -6.982 -13.448
    未计算非常项目前的净收益 -11.039 -10.241 -9.083 -6.982 -13.448
    净收入 -11.039 -10.241 -9.083 -6.982 -13.448
    Total Adjustments to Net Income 0
    普通股股东可获收益 (不含非经常性项目) -11.039 -10.241 -9.083 -6.982 -13.448
    普通股股东可获收益 (含非經常性項目) -11.039 -10.241 -9.083 -6.982 -13.448
    摊薄净收入 -11.039 -10.241 -9.083 -6.982 -13.448
    摊薄后加权平均股 67.4539 66.4699 66.4496 65.7323 63.6675
    扣除特别项目的每股摊薄盈利 -0.16365 -0.15407 -0.13669 -0.10622 -0.21122
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.16365 -0.15407 -0.13669 -0.10622 -0.21122
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 25.795 32.714 0.08246 0.06949 0.03019
    现金和短期投资 20.054 27.605 0.00047 0.00001 0.01108
    Cash 20.054 27.605 0.00047 0.00001 0.01108
    Prepaid Expenses 5.734 5.109 0.08199 0.06948 0.01911
    Total Assets 25.816 32.729 6.05041 32.0747 70.7962
    Long Term Investments 5.96795 32.0052 70.766
    Total Current Liabilities 15.585 11.923 0.60951 0.62244 0.56741
    Payable/Accrued 0.60951 0.62244 0.5511
    Accrued Expenses 4.513 1.632 0
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 18.407 11.923 3.93664 2.57421 1.25741
    Total Long Term Debt 2.822 0 2.67204 1.95176 0.69
    Total Equity 7.409 20.806 2.11376 29.5005 69.5387
    Common Stock 0.067 0.059 0.00269 24.5033 64.5415
    Additional Paid-In Capital 230.339 203.99 2.83109 4.62766 5.03621
    Retained Earnings (Accumulated Deficit) -222.997 -183.243 -0.72002 0.3695 -0.03893
    Total Liabilities & Shareholders’ Equity 25.816 32.729 6.05041 32.0747 70.7962
    Total Common Shares Outstanding 66.443 58.8106 2.68824 5.14975 9.0355
    Other Current Liabilities, Total 1.293 6.086 0 0.01631
    Long Term Debt 2.822 2.67204 1.95176 0.69
    Preferred Stock - Non Redeemable, Net 0 0 0
    Other Liabilities, Total 0.6551
    Other Current Assets, Total 0.007 0
    Other Long Term Assets, Total 0.021 0.015
    Accounts Payable 2.076 3.687
    Current Port. of LT Debt/Capital Leases 7.703 0.518
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 21.756 25.795 24.801 32.414 43.584
    现金和短期投资 16.506 20.054 18.249 24.548 40.202
    Cash 16.506 20.054 18.249 24.548 40.202
    Prepaid Expenses 5.244 5.734 6.005 7.312 3.382
    Total Assets 21.78 25.816 24.824 32.433 43.601
    Long Term Investments
    Total Current Liabilities 22.064 15.585 8.042 7.081 11.912
    Payable/Accrued
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 22.064 18.407 8.042 7.081 11.912
    Total Long Term Debt 0 2.822 0 0 0
    Long Term Debt 0 2.822
    Other Liabilities, Total
    Total Equity -0.284 7.409 16.782 25.352 31.689
    Preferred Stock - Non Redeemable, Net 0 0
    Common Stock 0.07 0.067 0.068 0.067 0.067
    Additional Paid-In Capital 233.576 230.339 229.47 228.958 228.313
    Retained Earnings (Accumulated Deficit) -234.036 -222.997 -212.756 -203.673 -196.691
    Total Liabilities & Shareholders’ Equity 21.78 25.816 24.824 32.433 43.601
    Total Common Shares Outstanding 70.3097 66.443 67.6413 66.6413 66.6413
    应收账款总额，净额
    Accounts Receivable - Trade, Net
    Other Current Assets, Total 0.006 0.007 0.547 0.554
    Other Long Term Assets, Total 0.024 0.021 0.023 0.019 0.017
    Accounts Payable 3.776 2.076 2.168 3.078 4.311
    Accrued Expenses 4.797 4.513 4.803 3.146 2.947
    Current Port. of LT Debt/Capital Leases 12.189 7.703 0 0 0.52
    Other Current Liabilities, Total 1.302 1.293 1.071 0.857 4.134
    Other Equity, Total 0.106
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -39.754 -93.063 -1.08951 0.40843 0.0661
    经营活动产生的现金 -39.755 -37.703 -0.59862 -0.79273 -0.47319
    非现金物品 -0.704 60.256 0.30303 0
    营运资金的变化 0.699 -4.898 0.18787 -1.20116 -0.53929
    投资活动产生的现金 -0.01 -0.007 26.176 40.2466 -0.64761
    其他投资现金流量项目，总计 26.176 40.2466 -0.64761
    融资活动产生的现金 32.214 63.456 -25.577 -39.4649 0.6825
    融资现金流项目 0 11.05 0 -0.0075
    股票的发行（报废），净额 22.712 53.682 -26.2972 -40.7267 0
    债务的发行（退还），净额 9.502 -1.276 0.72027 1.26176 0.69
    现金净变化 -7.551 25.746 0.00046 -0.01107 -0.4383
    Cash Taxes Paid 0 0.17
    经营活动产生的现金 0.004 0.002
    资本支出 -0.01 -0.007
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -11.039 -39.754 -29.513 -20.43 -13.448
    Cash From Operating Activities -6.089 -39.755 -31.437 -25.171 -10.38
    Cash From Operating Activities 0.001 0.004 0.003 0.002 0.001
    Non-Cash Items 2.455 -0.704 -1.956 -2.534 -0.924
    Changes in Working Capital 2.494 0.699 0.029 -2.209 3.991
    Cash From Investing Activities -0.004 -0.01 -0.011 -0.006 -0.003
    Capital Expenditures -0.004 -0.01 -0.011 -0.006 -0.003
    Cash From Financing Activities 2.545 32.214 22.092 22.12 22.98
    Issuance (Retirement) of Stock, Net 2.545 22.712 22.61 22.638 22.98
    Net Change in Cash -3.548 -7.551 -9.356 -3.057 12.597
    Financing Cash Flow Items 0 0 0
    Issuance (Retirement) of Debt, Net 9.502 -0.518 -0.518
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Javitt (Jonathan C) Individual Investor 20.578 14468329 0 2023-04-27 LOW
    Javitt (Daniel C) Individual Investor 13.7154 9643234 0 2023-04-27 LOW
    Hurvitz (Chaim) Individual Investor 3.2818 2307453 162660 2023-04-27 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1023 1478153 34990 2023-03-31 LOW
    Willard (Stephen H) Individual Investor 1.4934 1050000 0 2023-04-27 LOW
    Flynn (Patrick John) Individual Investor 1.071 752996 162660 2023-04-27 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5386 378667 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.5242 368598 2718 2023-03-31 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.3281 230700 52000 2023-03-31
    Gorovitz (Aaron) Individual Investor 0.2906 204346 162660 2023-04-27 MED
    Glied (Sharon A) Individual Investor 0.2501 175828 162660 2023-04-27 MED
    Besthof (Robert) Individual Investor 0.233 163827 140117 2023-04-27 MED
    Orfeo Capital SGIIC SA Investment Advisor 0.1841 129449 117224 2022-09-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1625 114240 0 2023-03-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.1147 80623 52895 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1013 71241 12643 2023-03-31 LOW
    Texas Capital Bank Private Wealth Advisors Investment Advisor 0.09 63290 0 2023-03-31 LOW
    HBKS Wealth Advisors Investment Advisor 0.0831 58460 58460 2022-12-31 MED
    Van Voorhees (Seth L) Individual Investor 0.0659 46337 0 2023-04-27 HIGH
    Virtu Americas LLC Research Firm 0.0657 46210 46210 2023-03-31 HIGH

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    NRx Pharmaceuticals, Inc. Company profile

    关于 NRx Pharmaceuticals Inc.

    NRX Pharmaceuticals, Inc.的前身是Big Rock Partners Acquisition Corp.，是一家以病人为中心的临床阶段制药公司。 该公司专注于开发NRX-101。 NRX-101是一种治疗双相情感障碍的急性自杀行为/痴呆的口服治疗药物，以及治疗COVID-19呼吸衰竭的静脉注射和吸入药物ZYESAMI (aviptadil)。 NRX-101旨在提供一种口服、快速发作和持续的家庭使用疗法，可以延长氯胺酮的抗自杀益处，并减少氯胺酮的副作用。 公司将D-环丝氨酸（DCS）（一种N-甲基-D-天门冬氨酸（NMDA）受体调节剂）和鲁拉西酮（一种5-HT2a受体拮抗剂）相结合。 NRX-101正处于临床测试的第三阶段。

    Industry: Biotechnology & Medical Research (NEC)

    1201 Orange Street
    Suite 600
    WILMINGTON
    DELAWARE 19801
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Gold

    1,946.19 Price
    -0.850% 1D Chg, %
    多头隔夜费 -0.0090%
    空头隔夜费 0.0008%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    US100

    14,304.60 Price
    -1.820% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    XRP/USD

    0.52 Price
    -0.220% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00396

    Oil - Crude

    72.36 Price
    +1.300% 1D Chg, %
    多头隔夜费 -0.0156%
    空头隔夜费 -0.0063%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易